Charlotte Lawthom

The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Anthony G Marson, Girvan Burnside, Richard Appleton et al. · The Lancet · 2021 · 202 citations · Full text

The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Anthony G Marson, Girvan Burnside, Richard Appleton et al. · The Lancet · 2021 · 183 citations · Full text

The impact of epilepsy on quality of life: Findings from a European survey

Adam Strzelczyk, Ángel Aledo‐Serrano, Antonietta Coppola et al. · Epilepsy & Behavior · 2023 · 105 citations

Nasal Retinal Nerve Fiber Layer Attenuation: A Biomarker for Vigabatrin Toxicity

Charlotte Lawthom, Phil E M Smith, John M. Wild · Ophthalmology · 2009 · 59 citations

Ocular Disease, Retina, Allergy +5

Forecasting stroke-like episodes and outcomes in mitochondrial disease

Yi Shiau Ng, Nichola Z. Lax, Alasdair Blain et al. · Brain · 2021 · 59 citations · Full text